Mesoblast
MESO
72 hedge funds and large institutions have $53.3M invested in Mesoblast in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 6 closing their positions.
908% more call options, than puts
Call options by funds: $34M | Put options by funds: $3.38M
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
5% more capital invested
Capital invested by funds: $50.5M → $53.3M (+$2.76M)
4% more funds holding
Funds holding: 69 → 72 (+3)
0.44% more ownership
Funds ownership: 2.55% → 2.99% (+0.44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Asset Management
Paris,
France
|
+$3.86M |
| 2 |
Morgan Stanley
New York
|
+$3.04M |
| 3 |
AAP
Arax Advisory Partners
Denver,
Colorado
|
+$2.13M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |
| 2 |
Jane Street
New York
|
-$976K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$593K |
| 4 |
HF
HRT Financial
New York
|
-$526K |
| 5 |
FFA
Fi3 Financial Advisors
Indianapolis,
Indiana
|
-$507K |
MESO Hedge Fund Activity: Q2 2026 in Review
72 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2026, worth a combined $53.3M — up 5.5% from $50.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MESO positions and 6 closed out — a net gain of 3 holders — while 24 added to existing stakes and 20 trimmed.
The largest buyer was BNP Paribas Asset Management, opening a new position worth an estimated $3.86M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.28M sold.
- 72 institutional investors held Mesoblast (MESO) as of Q2 2026, up from 69 in Q1 2026.
- Funds reported $53.3M of Mesoblast stock for Q2 2026, up 5.5% quarter-over-quarter.
- 9 funds opened new Mesoblast positions in Q2 2026 and 6 closed out, a net change of +3 holders.
- The largest Mesoblast buyer in Q2 2026 was BNP Paribas Asset Management, an estimated $3.86M added.
- The largest Mesoblast seller in Q2 2026 was Citadel Advisors, an estimated $1.28M sold.
Based on aggregated 13F filings for Q2 2026.